BIT036- a likely candidate for curing COVID-19, page-1865

OK. First of all, we all know that a CR is required at some stage. I can't see any argument that would discount that.

At the beginning of the year, they had $700k in cash. They received about $1.6mil from memory as an R&D tax rebate. I believe that the burn rate was about $3mil - and maybe less this year because the actual trials are completed (we heard nothing on the COVID trials as yet).

I would not hold out much hope for TO etc. That really is dreaming. You won't see an SP in the $ range though - the prelim results don't point to anything exceptional. 20-30 cents settling SP is more likely.

If the final results are released soon and they are excellent, then BIT may want to act faster in order to get the biggest bang for their buck to fund a phase 3 trial.